Effects of mitiglinide and sulfonylureas in isolated canine coronary arteries and perfused rat hearts

• Published in: European journal of pharmacology 2006-02, Vol.531 (1), p.194-200
• Main Authors: Maruyama, Itaru, Tomiyama, Yoshitaka, Maruyama, Kazuyasu, Ojima, Kazuma, Kobayashi, Kumi, Kobayashi, Mamoru, Yamazaki, Yoshinobu, Kojima, Masami, Shibata, Nobuo
• Format: Article
• Language: English
• Subjects: Animals; Biological and medical sciences; Cardiac function; Cardiology. Vascular system; Coronary Circulation - drug effects; Coronary heart disease; Coronary perfusion flow; Coronary Vessels - drug effects; Coronary Vessels - physiology; Cromakalim - pharmacology; Dogs; Dose-Response Relationship, Drug; Glyburide - pharmacology; Heart; Heart - drug effects; Heart - physiology; Heart - physiopathology; Hypoglycemic Agents - pharmacology; In Vitro Techniques; Indoles - pharmacology; Ischemia-reperfusion; Isoindoles; K ATP channel; Male; Medical sciences; Mitiglinide; Myocardial Reperfusion Injury - physiopathology; Perfusion; Pharmacology. Drug treatments; Rats; Rats, Wistar; Sulfonylurea Compounds - pharmacology; Sulfonylureas; Time Factors; Vasodilation - drug effects; Vasodilator Agents - pharmacology
• ISSN: 0014-2999; 1879-0712
• DOI: 10.1016/j.ejphar.2005.11.060

Our aim was to compare the cardiovascular effects of mitiglinide ((+)-monocalcium bis[( 2S,3a,7a- cis)-α-benzylhexahydro-γ-oxo-2-isoindolinebutyrate] dehydrate), a novel hypoglycemic drug, with those of glibenclamide and glimepiride, two sulfonylurea drugs. In isolated canine coronary arteries (organ-bath method), mitiglinide, glibenclamide, and glimepiride competitively antagonized the cromakalim-induced relaxation (pA 2 values, 5.29, 7.36, and 7.49, respectively). In isolated perfused rat hearts (Langendorff method) subjected to a 12-min global ischemia followed by a 30-min reperfusion, mitiglinide (3 × 10 − 6 mol/l) altered neither the change in coronary perfusion flow nor the alterations in cardiac functions associated with reperfusion. In contrast, both glibenclamide (3 × 10 − 8 mol/l) and glimepiride (1 × 10 − 7 mol/l) significantly reduced coronary perfusion flow after reperfusion. Moreover, at 30 min of reperfusion: (1) glibenclamide induced a significant increase in left ventricular end-diastolic pressure and significant decreases in left ventricular systolic pressure, left ventricular developed pressure, and the maximum first derivative of left ventricular pressure, while (2) glimepiride induced significant decreases in left ventricular developed pressure and the maximum first derivative of left ventricular pressure. Thus, the cardiovascular effects of mitiglinide (at least, in these rat and dog preparations) may be weaker than those of glibenclamide and glimepiride.